Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

Item
http://www.wikidata.org/entity/Q27851999
CIViC databasePTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activationTemsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.PI3K pathway dependencies in endometrioid endometrial cancer cell lines.Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group studyFunction and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study.Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
P2860

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

Item
http://www.wikidata.org/entity/Q27851999
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@ast
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@en
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@nl
type
label
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@ast
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@en
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@nl
prefLabel
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@ast
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@en
Predicting everolimus treatmen ...... rcinoma: a GINECO group study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Predicting everolimus treatmen ...... arcinoma: a GINECO group study
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698